Atorvastatin

New data from Evolocumab ( Repatha ) cardiovascular outcomes trial ( FOURIER ) were presented at the 2017 National Lipid...


New detailed data from the phase 3 GAUSS-3 ( Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-3...


The aim of a study was to evaluate the effect of Atorvastatin on lipid lowering, cardiovascular events, and adverse events...


A study has analysed the treatment and control of dyslipidaemia in patients at high and very high cardiovascular risk being...


New detailed data from the phase 3 YUKAWA-2 study evaluating Evolocumab ( Repatha ), a novel investigational cholesterol-lowering medication, in...


Acute kidney injury ( AKI ) is common in patients undergoing cardiac surgery among whom it is associated with poor...


Recent trials have shown a reduction in the risk of major adverse cardiac events ( MACE ) with Simvastatin and...


Results from ETC-1002-009, a phase 2b study evaluating the efficacy and safety of ETC-1002 ( Bempedoic acid ) compared with...


Despite current standard-of-care, many patients at high cardiovascular disease ( CVD ) risk still have elevated low-density lipoprotein cholesterol (...


A study has determined all-cause mortality in patients with a first myocardial infarct who were treated with Simvastatin ( Zocor...


Secretory phospholipase A2 ( sPLA2 ) generates bioactive phospholipid products implicated in atherosclerosis. The sPLA2 inhibitor Varespladib has favorable effects...


A study looking at the data of thousands of patients who suffered myocardial infarctions has suggested treatment with high-potency statins...


Siltuximab ( Sylvant ) is an anti-interleukin-6 ( IL-6 ) chimeric monoclonal antibody that binds to human IL-6.1 IL-6 is...


Statins ( HMG-CoA reductase inhibitors ) are widely used medicines for patients with lipid disorders and in the primary and...


Edoxaban ( Lixiana ), an oral direct factor Xa inhibitor, is in development for thromboprophylaxis, including prevention of stroke and...


The purpose of the study was to compare the incidence of new-onset diabetes ( NOD ) with cardiovascular event reduction...


People who stop taking cholesterol drugs ( statins ) may be at an increased risk for developing Parkinson's disease, according...


Pfizer has informed Healthcare Professional of updated prescribing advice for Atorvastatin ( Lipitor ). The new advice relates to interactions...


Pfizer has informed Healthcare Professional of updated prescribing advice for Atorvastatin ( Lipitor ). The new advice relates to interactions...


A newly developed DNA vaccine appears safe and may produce beneficial changes in the brains and immune systems of individuals...